Skip to main content

Table 3 Combined age distribution of oral facial neoplasms biopsy results l

From: Oral maxillofacial neoplasms in an East African population a 10 year retrospective study of 1863 cases using histopathological reports

Dx

0–10

11–20

21–30

31–40

41–50

51–60

61–70

71–80

81–90

91 +

US

mean

Range

AME

2

36

54

33

14

11

3

1

-

-

18

30.52

5–75

MYX

5

4

5

1

1

1

1

-

-

-

3

22.42

6–64

AMEF

1

1

1

1

-

-

-

-

-

-

-

27.67

15–38

AOT

-

1

-

-

-

-

-

-

-

-

1

*

*

ODT

-

-

1

-

-

-

-

-

-

-

-

*

*

ODF

-

3

2

-

-

-

-

-

-

-

-

19.80

14–25

MAME

-

-

-

1

-

-

-

-

-

-

-

*

*

FIB

18

30

22

22

21

11

11

-

-

-

1

31.00

0.5–70

OF

          

2

  

CF

-

3

4

-

-

1

-

-

-

-

1

27.00

12–52

CHD

-

-

1

1

-

1

-

-

-

-

-

40.50

30–58

OST

2

2

4

-

-

-

-

-

-

-

1

21.60

8–41

OSS

-

1

1

1

3

-

-

-

-

-

1

35.20

20–45

FIS

1

1

-

2

-

-

-

-

-

-

1

26.00

6–40

CHS

-

1

2

3

1

-

-

-

-

-

1

30.71

14–49

MYXS

-

-

-

-

1

-

-

-

-

-

-

*

*

RCS

-

1

-

-

-

-

-

-

-

-

-

*

*

BUR

341

35

2

-

1

-

-

-

-

-

3

7.21

2–45

NHL

2

5

1

1

2

2

4

-

-

-

-

35.33

1.5–63

HLH

-

-

-

1

-

-

-

-

-

-

-

*

*

CPL

-

-

-

1

-

-

-

-

-

-

-

*

*

SCCa

1

2

18

28

56

78

51

20

4

2

23

*

*

ACa

2

1

3

1

2

3

-

2

-

-

3

54.50

18–80

UCa

-

-

2

4

5

3

2

2

-

-

1

49.22

23–72

NPCa

-

-

1

-

-

-

-

-

-

-

-

*

*

NKTca

-

-

-

-

1

-

-

-

-

-

-

*

*

Vca

-

-

1

1

-

3

-

-

1

-

-

53.84

22–80

BCCa

-

-

-

-

-

1

-

-

-

-

-

*

*

ADN

2

3

7

2

2

1

1

-

-

-

1

29.16

3.1–61

PLA

3

14

30

19

9

6

6

1

-

-

4

32.58

5–71

MOA

-

-

-

-

1

-

-

-

-

-

-

*

*

OCA

-

3

-

-

-

-

-

-

-

-

-

19.00

17–20

ADCa

-

2

6

6

4

9

2

3

-

-

-

46.78

18–80

ACCa

-

3

2

1

6

4

1

1

-

-

1

46.86

20–65

SGCa

-

-

-

-

1

2

-

-

-

-

-

52.50

47–60

MSCa

-

1

-

2

1

-

-

-

-

-

-

33.00

14–48

MECa

-

2

1

1

2

2

-

-

-

-

1

37.22

13–60

CaPLA

-

-

-

-

-

-

-

-

-

-

1

*

*

HAP

1

2

-

-

-

-

-

1

-

-

-

28.50

7–80

KS

30

32

176

109

34

11

4

-

-

-

13

31.78

1.6–68

HAS

-

-

-

-

-

-

-

-

-

-

1

*

*

GCM

4

-

1

-

1

-

-

-

-

-

-

12.93

.06–49

LEI

-

1

-

-

-

-

-

-

-

-

-

*

*

RHS

3

4

1

-

1

-

-

-

-

-

-

*

*

LPH

6

2

1

-

1

-

2

-

-

-

-

17.61

0.7–70

LPHS

-

-

1

-

-

-

-

-

-

-

-

*

*

LIP

3

7

6

2

2

3

-

-

2

-

4

33.30

1–88

LIS

-

-

-

1

-

1

-

-

-

-

-

51.50

36–67

MEP

1

-

-

-

-

-

-

-

-

-

-

*

*

MEL

-

-

-

1

-

1

2

1

-

-

2

60.60

40–72

HAM

2

3

-

-

-

-

1

-

-

-

-

18.00

5–70

PAP

16

18

11

3

3

-

2

-

-

-

4

16.87

.08–65

NEF

1

5

2

2

-

-

2

-

-

-

-

28.70

6–70

SCH

-

1

-

-

-

-

-

-

-

-

1

*

*

MSA

-

1

-

-

-

-

-

-

-

-

-

*

*

CEM

-

-

2

-

-

-

-

-

-

-

-

*

*

CHSY

-

1

-

-

-

-

-

-

-

-

-

*

*

REBA

1

-

-

-

-

-

-

-

-

-

-

*

*

TOTAL

448

232

372

251

176

155

95

32

7

2

93

 Â